Gary Fanjiang, MD, MBA, MS, is the vice president of global development at Amgen, where he leads research and development activities for the Biosimilars Business Unit. He oversees the nonclinical, clinical, and medical affairs activities across a portfolio of 10 molecules in various stages of development in multiple therapeutic areas and indications of use. He previously served as executive medical director of global development at Amgen. Prior to joining Amgen, he held multiple positions at Abbott over the course of 8 years, and he held the associate director of clinical research role at AstraZeneca. After graduating from Tufts University and completing his residency and fellowship, he served as a fellow of pediatric gastroenterology and nutrition at Massachusetts General Hospital.